Insulin action and substrate competition (Q40812874)

23 September 2017

1 reference

title

Insulin action and substrate competition (English)

1 reference

23 September 2017

Groop LC

1

1 reference

PubMed ID

8304911

23 September 2017

Ferrannini E

series ordinal

2

1 reference

23 September 2017

1 October 1993

1 reference

Bailliere's clinical endocrinology and metabolism

23 September 2017

1 reference

23 September 2017

7

1 reference

23 September 2017

1007-1032

1 reference

23 September 2017

4

1 reference

In vitro study of human skeletal muscle strips: effect of nonesterified fatty acid supply on glucose storage.

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effects of intravenous methyl palmoxirate on the turnover and oxidation of fatty acids in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Interrelation of carbohydrate and palmitate metabolism in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Operation of Randle's cycle in patients with NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

An abnormality of nonesterified fatty acid metabolism in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: evidence that this effect can be dissociated from the provision of reducing equivalents.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effects of fat on insulin-stimulated carbohydrate metabolism in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Obesity and insulin resistance in humans: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Studies on the metabolic effects induced in the rat by a high-fat diet. Inhibition of pyruvate metabolism in diaphragm in vitro and its relation to the oxidation of fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The effect of acipimox in patients with type 2 diabetes and persistent hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The theoretical bases of indirect calorimetry: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effect of fatty acids on glucose production and utilization in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Factors associated with basal metabolic rate in patients with type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Factors influencing the rates of long-chain fatty acid oxidation and synthesis in mammalian systems

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty a

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Carbohydrate and lipid oxidation in normal human subjects: Its influence on glucose tolerance and insulin response to glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Glucose metabolism in rat skeletal muscle at rest. Effect of starvation, diabetes, ketone bodies and free fatty acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effects of increased plasma fatty acids on glycogen utilization and endurance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Evidence for marked sensitivity to the antilipolytic action of insulin in obese maturity-onset diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The Antilipolytic Action of Insulin in Obese Subjects with Resistance to Its Glucoregulatory Action*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Oxidation of plasma FFA in lean and obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Acute changes in plasma non-esterified fatty acid concentration do not change hepatic glucose production in people with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antiinsulin receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Metabolic factors in the insulin resistance in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The Influence of Insulin on Glucose and Fatty Acid Metabolism in the Isolated Perfused Rat Hind Quarter

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Inhibition of glucose uptake and glycogenolysis by availability of oleate in well-oxygenated perfused skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

The Relationship Between Serum Free Fatty Acids and Blood Sugar in Non-obese and Obese Diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Role of Free Fatty Acids in Glucose Homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effects of fatty acids on carbohydrate and fatty acid metabolism of rat diaphragm

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Physiologic Effects of Metabolic Fuels on Carbohydrate Metabolism: I. Acute Effect of Elevation of Plasma Free Fatty Acids on Hepatic Glucose Output, Peripheral Glucose Utilization, Serum Insulin, and Plasma Glucagon Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effect of long chain triglyceride infusion on glucose metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation Selectively

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Mechanisms underlying regional differences in lipolysis in human adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effect of elevated free fatty acids on glucose oxidation in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Kinetics of glucose disposal in whole body and across the forearm in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980243-5

7 January 2021

10.1016/S0950-351X(05)80243-5

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8304911